JP Morgan Chase
MSAC

JP Morgan Chase’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

JP Morgan Chase’s Portfolio MSAC Stock Details MSAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$1K – 7503
2022
Q4 		$1K Hold
100
– – ﹤0.01% 6485
2022
Q3 		$1K Hold
100
– – ﹤0.01% 6408
2022
Q2 		$1K Hold
100
– – ﹤0.01% 6414
2022
Q1 		$1K Hold
100
– – ﹤0.01% 6519
2021
Q4 		$1K Buy
+100
New +$972 ﹤0.01% 6588

JP Morgan Chase's MSAC Position: Q1 2023 in Review

JP Morgan Chase sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 100 shares — an estimated $1K sold.

JP Morgan Chase first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $1K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

  • JP Morgan Chase reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 100 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $1K.
  • JP Morgan Chase first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • JP Morgan Chase's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.